Welcome to our dedicated page for Corvex SEC filings (Ticker: MOVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Movano Inc. (Nasdaq: MOVE) SEC filings page on Stock Titan provides direct access to the company’s official regulatory disclosures, along with AI-powered summaries that help explain their contents in plain language. Movano, doing business as Movano Health, files a range of documents with the U.S. Securities and Exchange Commission that together outline its wearable health technology business, capital structure, and significant corporate events.
Investors can review registration statements such as the Form S-1 that describes a committed equity facility with Chardan Capital Markets LLC, including the potential issuance of up to 110,000,000 shares of common stock under the facility and Movano’s status as an emerging growth company and smaller reporting company. The S-1 and related materials also discuss Nasdaq listing matters, reverse stock split effects on share counts, and stockholders’ equity considerations.
Current reports on Form 8-K document material events, including the Agreement and Plan of Merger with Corvex, Inc., the structure of the all-stock combination, expected ownership percentages of the combined company, and conditions to closing. Other 8-K filings cover the one-for-ten reverse stock split, Nasdaq deficiency notices and extensions, amendments to incentive plans, preferred stock financings, amendments to loan agreements, and stockholder meeting results. These filings provide detail on how Movano is addressing listing requirements, financing needs, and its planned transformation through the Corvex merger.
Definitive proxy statements on Schedule 14A offer insight into stockholder votes on matters such as increasing authorized share capital, approving share issuances under the ChEF Purchase Agreement, amending the omnibus incentive plan, and authorizing reverse stock splits. They also describe virtual special meeting logistics and voting procedures for common and preferred stockholders.
On Stock Titan, each filing is accompanied by AI-generated highlights that point out key terms, risk factors, and structural details, helping users navigate lengthy documents like S-1 registration statements and complex 8-K merger disclosures. The platform also makes it easier to locate quarterly and annual reports when filed (Forms 10-Q and 10-K), as well as any insider transaction reports on Form 4, so users can monitor executive and director share dealings once available.
By using this page, investors can quickly find Movano’s official SEC filings related to its wearable medical devices, financing arrangements, Nasdaq compliance efforts, and the proposed renaming and repositioning of the company as Corvex, Inc. after the merger closes, while relying on AI tools to surface the most important information from each document.
Corvex, Inc. director Seth Demsey reported automatic conversions of Series B Preferred Stock into Common Stock on March 31, 2026. The filing shows 24.5327 shares of Series B Preferred Stock converting into 24,532 shares of Common Stock held directly, and 0.1399 preferred shares converting into 139 common shares held indirectly.
After the transactions, Demsey directly holds 3,078,767 shares of Common Stock. The indirect Common Stock is held through Ainsworth Holdings, LLC, where Demsey is the managing member and has sole voting and dispositive power but disclaims beneficial ownership except for his pecuniary interest. The Series B Preferred Stock converts at a 1-to-1,000 ratio and is perpetual with no expiration date.
Corvex, Inc. Chief Executive Officer Crystal John Adler III reported automatic conversions of Series B Preferred Stock into common stock on March 31, 2026. A total of 14.9652 shares of Series B Preferred Stock converted into 14,965 shares of common stock held directly, bringing his direct common stock holdings to 3,069,200 shares, which include unvested restricted stock units. An additional 3.1677 shares of Series B Preferred Stock converted into 3,167 shares of common stock held indirectly in the John Adler Crystal III Roth IRA, an account over which he has sole voting and dispositive power while disclaiming beneficial ownership beyond his pecuniary interest.
Corvex, Inc. director Emily Fairbairn reported a conversion of preferred stock into common shares. On March 31, 2026, 9.2319 shares of Series B Convertible Preferred Stock automatically converted into 9,231 shares of common stock at a 1-to-1,000 conversion ratio, with fractional shares paid in cash.
The new common shares are held indirectly through affiliated entities where Fairbairn has voting and investment power, and she disclaims beneficial ownership beyond her pecuniary interest. Following these transactions, she holds 68,369 common shares directly and additional indirect holdings of 22,232 and 3,522 common shares through separate entities.
Movano Inc. submitted a Form 144 notice for proposed sales of its Class A Common Stock and restricted securities. The cover lists multiple share amounts tied to different dates, including 5,000, 57,720, 1,141,930, 9,684, and a reported sale of 19,967 shares on 01/14/2026. The filing names Michael Leabman as a holder associated with the sale notice.
Corvex, Inc. Chief Executive Officer Crystal John Adler III reports his initial ownership in MOVE. He directly holds 3,054,235 shares of common stock and an incentive stock option covering 2,902,143 shares at an exercise price of $10.06 per share expiring on March 19, 2036.
He also holds Series B and Series C convertible preferred stock that will convert into common stock, including portions held through the John Adler Crystal III Roth IRA trust. Some Series B shares automatically convert on March 31, 2026, while the Series C conversion is contingent on stockholder approval under the Movano–Corvex Merger Agreement.
Corvex, Inc., formerly Movano Inc., filed its annual report detailing a major transformation driven by its March 19, 2026 merger with Corvex Legacy Holdings. The combined company now operates two divisions: an AI cloud computing business focused on GPU-accelerated infrastructure and a legacy healthcare wearables business.
The AI division runs high-density NVIDIA GPU clusters in a Tier III-designed data center, targeting model training and inference with reserved-capacity contracts and strategic partnerships, including NVIDIA. The healthcare division includes the Wellness Ring and an FDA 510(k)-cleared Medical Ring, though Wellness Ring sales are currently paused and a sale of healthcare assets is being explored.
The report emphasizes that all audited financial statements and MD&A reflect only the pre-merger Movano healthcare operations; Corvex OpCo’s AI cloud results are not yet included. As of March 19, 2026, the capital structure comprised 1,208,857 common shares and multiple series of preferred stock outstanding, with significant potential dilution upon preferred conversions.
Corvex, Inc. director Demsey Seth filed an initial Form 3 reporting his equity holdings in MOVE. He reports direct ownership of 3,054,235 shares of common stock and an incentive stock option covering 2,902,143 shares of common stock at an exercise price of $10.06 per share, expiring in 2036.
He also holds Series B and Series C convertible preferred stock that are exchangeable into common shares, including amounts received in connection with the merger in which Movano Inc. combined with Corvex and was renamed Corvex, Inc. Certain preferred holdings, including 140 underlying Series B shares and 31,270 underlying Series C shares, are held indirectly through Ainsworth Holdings, LLC, where he is managing member and disclaims beneficial ownership except to the extent of his pecuniary interest.
Movano Inc. director Emily Fairbairn reported three acquisitions of derivative securities. She received Series B Preferred Stock that automatically converts into common stock on March 31, 2026 at a 1-for-1000 ratio, and perpetual Series C Preferred Stock that will convert at a 1-for-1000 ratio upon stockholder approval under Nasdaq rules.
These preferred shares were received in exchange for her Corvex, Inc. equity in connection with a merger agreement. She also received a stock option for 200,000 shares of common stock at an exercise price of $15.09 per share, vesting in three equal annual installments and becoming exercisable only after shareholder approval of the award.
Cogan Jeremy reported acquisition or exercise transactions in this Form 4 filing.
Movano Inc. CFO Jeremy Cogan reported an equity compensation grant rather than an open-market trade. He received 37,000 shares of Common Stock on March 18, 2026, reflecting a grant of restricted stock units under the company’s Omnibus Incentive Plan. After this award, his direct holdings total 97,504 shares of Movano Inc. common stock. This filing records routine executive compensation and does not indicate a discretionary stock purchase or sale.
Movano Inc. completed an all‑stock merger with AI cloud company Corvex, Inc., making Corvex a wholly owned subsidiary and shifting the combined business toward GPU‑accelerated AI infrastructure. Movano will change its name to Corvex, Inc. effective March 23, 2026, while its stock continues to trade on Nasdaq under the symbol MOVE.
At closing, Movano issued 240.562 shares of Series B Convertible Preferred Stock, 23,551.5195 shares of Series C Non‑Voting Convertible Preferred Stock and 30,227.0524 shares of Series D Non‑Voting Convertible Preferred Stock to Corvex securityholders. Each Series B share will automatically convert into 1,000 common shares on March 31, 2026, and the Series C and D preferred shares will convert into, or be convertible into, 1,000 common shares per preferred share following stockholder approval of a Conversion Proposal.
The company also declared a stock dividend of 0.358 share of common stock for every outstanding common share, payable to stockholders of record on March 30, 2026 and distributable on April 6, 2026. As a result of the transaction, management reports stockholders’ equity now exceeds Nasdaq’s $2.5 million minimum, addressing a prior delisting risk.
The filing details new Series B, C and D preferred terms, Board reconstitution with Corvex co‑founder Seth Demsey joining as a director, planned appointment of Corvex co‑founders Jay Crystal and Mr. Demsey as Co‑Chief Executive Officers after the 2026 stockholders’ meeting, a new director compensation framework, and extended loan maturity to June 30, 2026. Overall, the merger transforms Movano into an AI infrastructure‑focused public company with reworked capital structure and governance.